← All companies
GBCS
Selectis Health, Inc.
$5.40
-0.01 -0.18%
Key statistics
from XBRL data in SEC filingsMarket cap
$16.6M
Revenue (TTM)
$38.2M
Net income (TTM)
$6.17M
EPS (TTM)
$1.78
P/E ratio
3.0
Dividend yield
—
Free cash flow
$1.44M
Cash
$1.29M
Total assets
$30.0M
Gross margin
—
52-week range
$1.50 – $5.60
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Entered a material agreement; Regulation FD disclosure
Jun 24, 2026
10-Q
Quarter ended 2026-03-31
May 22, 2026
8-K
Director or officer change
May 20, 2026
8-K
Completed an acquisition or disposition
May 7, 2026
10-K
Fiscal year ended 2025-12-31
Apr 15, 2026
8-K
Director or officer change
Mar 31, 2026
8-K
Director or officer change
Mar 19, 2026
8-K
Entered a material agreement
Mar 9, 2026
8-K
Completed an acquisition or disposition
Jan 21, 2026
8-K
Director or officer change
Jan 6, 2026
8-K
Took on a direct financial obligation; Modified rights of security holders
Dec 30, 2025
8-K
Entered a material agreement
Dec 9, 2025
10-Q
Quarter ended 2025-09-30
Nov 14, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Terminated a material agreement
Jul 16, 2025
8-K
Other events
Jun 20, 2025
10-Q
Quarter ended 2025-03-31
May 21, 2025
10-K
Fiscal year ended 2024-12-31
Apr 15, 2025
8-K
Entered a material agreement
Feb 13, 2025
8-K
Director or officer change
Jan 23, 2025
8-K
Changed accountants
Dec 9, 2024
8-K
Changed accountants
Nov 22, 2024
10-Q
Quarter ended 2024-09-30
Nov 14, 2024
10-K/A
Fiscal year ended 2023-12-31
Oct 4, 2024
8-K
Director or officer change
Oct 1, 2024
8-K
Director or officer change
Aug 29, 2024
10-Q
Quarter ended 2024-06-30
Aug 16, 2024
8-K
Director or officer change
Jul 11, 2024
8-K
Completed an acquisition or disposition
Jun 25, 2024
10-Q
Quarter ended 2024-03-31
May 15, 2024
8-K
Regulation FD disclosure
May 9, 2024
8-K
Entered a material agreement
May 8, 2024
8-K
Took on a direct financial obligation
Apr 23, 2024
10-K
Fiscal year ended 2023-12-31
Apr 16, 2024
8-K
Director or officer change
Mar 25, 2024
8-K
Director or officer change
Mar 25, 2024
8-K
Terminated a material agreement
Feb 22, 2024
8-K
Director or officer change; Regulation FD disclosure
Dec 22, 2023
8-K
Entered a material agreement; Regulation FD disclosure
Dec 5, 2023
10-Q
Quarter ended 2023-09-30
Nov 13, 2023